Japan Results Roundup: Global Mainstays And Forex Boost Top Lines

Mostly strong global sales of mainstay drugs, along with a forex boost, helped Japan's major pharma firms in the fiscal third quarter and calendar year.

Japan's Q4 results
(Shutterstock)

More from Japan

More from Focus On Asia